Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients.
Oncologist
; 26(8): e1483, 2021 Aug.
Article
in En
| MEDLINE
| ID: mdl-33978307
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Oncologist
Year:
2021
Document type:
Article